Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$27,492,676
+$3,464,599 QoQ
Shares Held
109,254
-1.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
3.65%
of 13F equity value
Holder Rank
#512
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Violich Capital Management, Inc. holds $62,484,887 across 7 Drug Manufacturers - General names. ABBV ranks #1 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
109,254 | $27,492,676 | |
| 2 | JNJ |
Johnson & Johnson
|
87,990 | $22,346,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,257 | $6,458,024 | |
| 4 | AMGN |
Amgen Inc
|
9,350 | $3,385,822 | |
| 5 | LLY |
ELI LILLY & Co
|
1,291 | $1,548,464 | |
| 6 | PFE |
Pfizer Inc
|
26,350 | $634,508 | |
| 7 | NVS |
Novartis AG
|
3,947 | $618,573 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,492,676 | 109,254 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $24,028,077 | 110,479 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $25,452,415 | 111,394 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $25,556,459 | 110,376 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $19,331,394 | 104,145 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $24,496,030 | 116,915 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $20,808,136 | 117,097 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $23,156,702 | 117,261 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $19,979,678 | 116,486 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $21,022,716 | 115,446 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $17,175,480 | 110,831 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $16,435,951 | 110,264 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $15,593,380 | 115,738 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $19,002,960 | 119,238 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,283,790 | 119,323 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $16,041,181 | 119,523 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $18,326,972 | 119,659 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $19,432,287 | 119,871 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $16,366,204 | 120,873 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $12,861,447 | 119,231 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $13,025,802 | 115,641 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $12,834,459 | 118,596 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $12,622,377 | 117,801 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $10,269,139 | 117,241 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $12,185,807 | 124,117 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $9,398,950 | 123,362 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||